SPEAKERS

Your Expert Speakers: Drug Developers, Academics & Associations

Aaron Schetter

Senior Director, Regulatory Affairs, Companion Diagnostics

Daiichi Sankyo, Inc.

Amy Gorman

Director, Global Commercial Strategy, Precision Medicine

Janssen

Antonio Chambers

Associate Director, Technical Diagnostic Testing Services

Eli Lilly and Company

Brian Baker

Senior Director, Regulatory Affairs (CDx)

Regeneron

Christine Martersteck

Manager Diagnostic Development

Loxo Oncology at Lilly

Deepti Aurora-Garg

Executive Director, Companion Diagnostics | Vice President Companion Diagnostics

Merck | Prometheus Biosciences

Dun Liang

Director, Regulatory Affairs, CDx

Loxo Oncology at Lilly

Heather Cohen

Director, Translational Sciences and Diagnostics

Bicycle Therapeutics

Hilary Gee Goeckner

Senior State and Local Campaigns Manager, Access to Care

American Cancer Society Cancer Action Network

James Hewitt

IVD Product Expert

TÜV SÜD

Jason Baum

Vice President, Translational Medicine

Leap Therapeutics

Javier Perez

Director, Precision Medicine, Companion Diagnostics

Regeneron

Jeffrey Siegel

Office Director, Office of Drug Evaluation Sciences, OND

CDER U.S. Food and Drug Administration

Jie Cheng

Senior Director, Statistical and Quantitative Sciences

Takeda Pharmaceutical Company

John Yi

Director, Translational Medicine

G1 Therapeutics

Kaska Kowanetz

Director, Global Regulatory Lead

Pfizer

Keith Wharton

Vice President, Medical Director

Ultivue

Lakshman Ramamurthy

Head of Global Regulatory Affairs, Precision Medicine & Digital Health

GlaxoSmithKline

Lindsay Darling

Associate Director, Companion Diagnostics Portfolio Management & Operations

Regeneron

Maureen Lane

Vice President, Clinical Science

Curis Inc.

Meijuan Li

Vice President, Head of Biostatistics, Oncology Group

Eisai

Melinda Day

Associate Director, Translational Clinical Development

Kronos Bio

Michael Lahn

Chief Executive Officer

iOnctura

Michael Rivers

Vice President and Lifecycle Leader, Digital Pathology

Roche Tissue Diagnostics

Minakshi Guha

LBx Strategy Lead, Companion Diagnostics

Takeda Pharmaceuticals Inc

Minghao Song

Director, Precision Medicine Lead

AstraZeneca

Pamela Ebrahimi

Deputy Branch Chief, Molecular Genetics Branch

CDRH, U.S. Food and Drug Administration

Qing Li

Head of Clinical Biomarker & CDx Strategy

H3 Biomedicine

Sarah Hersey

Vice President, Precision Medicine

Bristol Myers Squibb

Satya Saxena

Director, Global Proteomics, Clinical Pharmacology and Translational Medicine, Neurology Business Group

Eisai

Shirin Khambata Ford

Vice President, Head Companion Diagnostics, Global Companion Diagnostics, Global Oncology R&D

Daiichi Sankyo

Si Tuen-Lee Hoeflich

Director

Scholar Rock

Sid Mathur

Regulatory Affairs Executive Director, Companion Diagnostics

Merck

Silva Krause

Senior Director, Clinical Biomarkers

Vertex Pharmaceuticals

Srinivas Venkatram

Director, CDx Strategy

AbbVie

Steve Anderson

Consultant

Precision Medicine & Oncology

Susanne Rhoades

Senior Director, Diagnostic Development

Loxo Oncology at Lilly

Victoria Rimkunas

Senior Director, Head of Translational Medicine

Repare Therapeutics

Wenora Johnson

Research & Patient Advocate

Zhen Su

Chief Executive Officer

Marengo Therapeutics